PROPHYLACTIC LAMIVUDINE AND VERY-LOW DOSE HBIG PREVENT HBV RECURRENCEPOST LIVER-TRANSPLANT WHILE RESCUE THERAPY WITH LAMIVUDINE IS ASSOCIATED WITH SIGNIFICANT RESISTANCE AND GRAFT LOSS
G. Mccaughan et al., PROPHYLACTIC LAMIVUDINE AND VERY-LOW DOSE HBIG PREVENT HBV RECURRENCEPOST LIVER-TRANSPLANT WHILE RESCUE THERAPY WITH LAMIVUDINE IS ASSOCIATED WITH SIGNIFICANT RESISTANCE AND GRAFT LOSS, Hepatology, 28(4), 1998, pp. 402-402